ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Nurexone Biologic Inc

Nurexone Biologic Inc (NRX)

0.63
-0.04
(-5.97%)
Closed July 25 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.63
Bid
0.63
Ask
0.67
Volume
38,123
0.61 Day's Range 0.64
0.185 52 Week Range 1.19
Market Cap
Previous Close
0.67
Open
0.61
Last Trade
250
@
0.65
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
73,688
Shares Outstanding
48,249,000
Dividend Yield
-
PE Ratio
-8.36
Earnings Per Share (EPS)
-0.08
Revenue
-
Net Profit
-3.64M

About Nurexone Biologic Inc

Sector
Miscellaneous Metal Ores,nec
Industry
Pharmaceutical Preparations
Headquarters
Toronto, Ontario, Can
Founded
2011
Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Exchange with ticker NRX. The last closing price for Nurexone Biologic was $0.67. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0.185 to $ 1.19.

Nurexone Biologic currently has 48,249,000 shares outstanding. The market capitalization of Nurexone Biologic is $32.33 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -8.36.

NRX Latest News

Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma

TORONTO and HAIFA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

Updates from NurExone: Growth Conference Presentation and Website Relaunch

TORONTO and HAIFA, Israel, July 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market

TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development

TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application

TORONTO and HAIFA, Israel, June 11, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders

TORONTO and HAIFA, Israel, June 04, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials

TORONTO and HAIFA, Israel, May 29, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company...

NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations

TORONTO and HAIFA, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

Shares of Biopharma Up After News of Uplisting

When firms uplist to a higher exchange, they gain visibility and greater access to investors. And today, news of a strategic expansion in the United States is sending shares of this biopharma To...

Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies

For anyone with a spinal cord injury (SCI), time is of the essence. The typical treatment scenario involves immobilization and surgery as quickly as possible. After that, managing To read the full...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.08-11.26760563380.710.740.61795600.72324945CS
4-0.1-13.6986301370.730.750.61710650.6965585CS
120.011.612903225810.620.870.46736880.68372825CS
260.335113.5593220340.2951.190.271260060.76087335CS
520.325106.5573770490.3051.190.185824170.73572008CS
156-0.17-21.250.81.190.1556510.70583477CS
260-0.17-21.250.81.190.1556510.70583477CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BFIBurgerFi International Inc
$ 0.5141
(141.25%)
12M
WINTWindtree Therapeutics Inc
$ 4.60
(39.82%)
364.99k
SPECSpectaire Holdings Inc
$ 0.5459
(36.48%)
5.45M
CLLSCellectis SA
$ 2.34
(14.15%)
327.39k
NUVOHoldco Nuvo Group DG Ltd
$ 0.80
(13.80%)
45.95k
DXCMDexCom Inc
$ 72.40
(-32.87%)
2.93M
ZYXIZynex Inc
$ 8.70
(-14.62%)
13.87k
JEWLAdamas One Corporation
$ 0.366
(-10.95%)
1.2k
NVNINVNI Group Ltd
$ 1.7065
(-9.71%)
181.96k
TNDMTandem Diabetes Care Inc
$ 37.00
(-8.98%)
76.52k
BFIBurgerFi International Inc
$ 0.5141
(141.25%)
12M
SPECSpectaire Holdings Inc
$ 0.5459
(36.48%)
5.45M
NVDANVIDIA Corporation
$ 111.56
(-0.64%)
3.86M
DXCMDexCom Inc
$ 72.40
(-32.87%)
2.93M
QDELQuidelOrtho Corporation
$ 38.24
(0.00%)
2.69M

Discussion

View Full Feed
spdpro spdpro 5 minutes ago
same with the AM 9:25 to 9:30
ClayTrader ClayTrader 5 minutes ago
Like I said, got some "tip" on this one. That's a sign of a pump and dump. You then also confirmed you "got a tip". Now I'm simply replying to all the nonsense being thrown at me.

You can name call all you want. It does nothing to a rational thinker other than make you look like you h
HIRU
Carjockey2 Carjockey2 5 minutes ago
Quite familiar with Clayton..

:-)
HIRU
Menace212 Menace212 5 minutes ago
ATTENTION

LOOK ON OTC MARKETS

The supplementary file is now inactive stating qatar
HIRU
newmedman newmedman 5 minutes ago
easy there cowboy... You'll at least have to buy me dinner and I'm still not that easy...You're lucky I quit drinking or you'd be calling up a loan officer before you even got a chance to see what's under my hood.
Its_TradingG Its_TradingG 6 minutes ago
"I'll ride this down into the ground till the DD changes." at least you know what's coming, anyone with a brain would not listen to this pumping POS clown
IGPK
Jack_Herer Jack_Herer 6 minutes ago
The mines are worth diddly...
The Ni mining business in Aus is shuttered thanks to Indonesia, and placer Au in Liberia? Gimme a break... 🤣
HIRU
noradio noradio 6 minutes ago
Let's put it this way, he has an interview with Janice shell on youtube, that tells you everything you need to know about the guy.
HIRU
Tomorrowneverknows Tomorrowneverknows 6 minutes ago
Hell Clay and Matt were best buddies .. Clay got his start pumping a scam muffler company then all of sudden out he goes and comes back with a deal with scumhub..
HIRU
webprods webprods 6 minutes ago
Get da f… from our great board. You know that you are crook.
HIRU
Carjockey2 Carjockey2 6 minutes ago
It's obvious!!!!!

Send in the clowns
HIRU
Its_TradingG Its_TradingG 7 minutes ago
SCAM
IGPK
Carjockey2 Carjockey2 7 minutes ago
Wholly crap..

It's all making sense now with ASCM and shorter's..

SENT IN CLAY

LOL
HIRU
Natural Trader Natural Trader 7 minutes ago
will do buddy thnx!!!
noradio noradio 7 minutes ago
Clay why didn't you show up as we rallied from trips to .005?
HIRU
Buellersback Buellersback 7 minutes ago
Time will tell if that's true. 2 weeks is too small of a sample.
RGLG
nwtf nwtf 7 minutes ago
Youre a proven liar. Nothing more needs to be said.
ERHE
peafunke peafunke 7 minutes ago
The “$” was a typo
TPTW
zakattack zakattack 8 minutes ago
Just delist already what is the point of having this around if you arent gonna do anything
GNCP
mascale mascale 8 minutes ago
HIRU OTC Pink Current w/mining project details posted: OTC. Some of the names have become confidential, anyone might guess: In the current public sphere, maybe affecting even royalty(?).
HIRU
webprods webprods 8 minutes ago
You are right. Claytrader is a crook. He destroying any a good movement of the stock. Ignore this a… le.
HIRU

Your Recent History

Delayed Upgrade Clock